3 results
Search Results
Now showing 1 - 3 of 3
Article Toxoplasma gondii Coinfection in HIV-Positive Patients at a Tertiary Care Hospital(Bentham Science Publ Ltd, 2025) Kurkcu, Muhammed Furkan; Bakir, Ayfer; Kaba, Semiha Berra Topsakal; Kusabbi, Ilknur Alkan; Usluca, SelmaIntroduction: Toxoplasma gondii (T. gondii) can cause serious complications in both immunocompetent and immunosuppressed individuals. This study aims to assess the seroprevalence of T. gondii among HIV-positive individuals and to investigate its association with age, sex, CD4+ T cell count, HIV RNA levels, and hematological parameters. Methods: This study included 247 HIV-positive individuals followed up at a tertiary care hospital between November 1, 2022, and November 30, 2024. We analyzed serum samples for T. gondii IgG antibodies using electrochemiluminescent microparticle immunoassay. Results: The prevalence of T. gondii IgG seropositivity was found to be 32.8% (n=81; 95% CI: 26.9-39). The median age of seropositive individuals was 52 years (IQR: 42-61), which was significantly higher compared to seronegative individuals (p<0.001). The highest IgG seropositivity rate (66.7%) was observed in the 61-80 age group. Hemoglobin levels were significantly lower in IgG seropositive individuals (p=0.040). Logistic regression analysis indicated an increased risk of T. gondii infection with advancing age. The odds ratio for the 41-60 age group was 13.3 (95% CI: 1.6-106, p=0.02), while for the 61-80 age group, it was 28 (95% CI: 3.3-240, p=0.002). Discussion: The seroprevalence of T. gondii in HIV-positive individuals was lower than both global and regional averages. Age was identified as an independent risk factor for T. gondii seropositivity. Additionally, hematological alterations associated with anemia were observed in seropositive individuals. Further large-scale, multi-center, and regionally representative studies are required to optimize T. gondii infection management and screening strategies in people living with HIV. Conclusion: These findings suggest that T. gondii infection in HIV-positive individuals increases with age and may be associated with anemia, highlighting the need for age-focused screening and management strategies.Article Detection of Toxoplasma Gondii and High-Risk Human Papillomaviruses in FFPE Malignant and Benign Breast Lesions Using Real-Time Pcr(Dove Medical Press Ltd, 2025) Usluca, Selma; Bakir, Ayfer; Arikok, Ata Turker; Korkut, Gizem; Yagiz, Gulsah Ceylan; Alper, MuratObjective: Breast cancer is the most prevalent malignancy among women. In recent years, it has been suggested that various pathogens such as Toxoplasma gondii (T. gondii) and human papillomavirus (HPV) may play a potential role in the development of breast cancer. This study aimed to determine the prevalence of T. gondii and HPV infections in formalin-fixed paraffin-embedded tissue samples of breast cancer patients using real-time PCR. Methods: The study included 136 paraffin-embedded biopsy samples with w confirmed malignant breast tumor diagnosis and 50 breast tissue samples diagnosed as benign breast lesions, serving as controls. The presence of T. gondii DNA and high-, medium-, and low-risk HPV genotype DNAs were investigated using the real-time PCR method. First, deparaffinization was performed using xylene and alcohol, followed by DNA extraction and real-time PCR amplification. Results: The most common histopathological types of malignant breast carcinoma were invasive carcinoma (n=82; 60.3%), invasive lobular carcinoma (n=26; 19.1%), invasive ductal carcinoma (n=8; 5.9%), and mixed invasive carcinoma (n=8; 5.9%). According to the Modified Bloom-Richardson classification, 55.15% of malignant breast tumor samples were grade 2, 32.4% were grade 3, and 12.5% were grade 1. Real-time PCR analysis did not detect T. gondii DNA or HPV DNA in any of these samples. Conclusion: Our findings do not support a role of T. gondii and HPV in breast cancer development. To better understand the possible relationship between breast cancer and these pathogens, further studies with larger sample sizes, diverse diagnostic methods, and broder geographical coverage are necessary.Article Prevalence of Toxoplasma Gondii in Patients with Schizophrenia and Its Association with Clinical Symptoms(Pergamon-Elsevier Science Ltd, 2025) Kurkcu, Muhammed Furkan; Korkut, Gizem; Varli, Mehmet Ridvan; Yilmaz, Gulsum; Usluca, Selma; Bakir, AyferBackground: Schizophrenia is a multifactorial neuropsychiatric disorder influenced by both genetic predisposition and environmental factors. Recent evidence suggests a possible link between latent Toxoplasma gondii infection and schizophrenia, though the underlying mechanisms remain unclear. Objective: To compare the seroprevalence of T. gondii in patients with schizophrenia and healthy individuals, and to evaluate the relationship between seropositivity and clinical parameters. Methods: A total of 265 participants (155 schizophrenia patients and 110 healthy controls) were enrolled. IgG and IgM antibodies were detected using electrochemiluminescence immunoassay (ECLIA), avidity was assessed using ELISA, and DNA presence was tested with real-time PCR. Clinical symptoms were evaluated using the Brief Psychiatric Rating Scale (BPRS). Statistical analysis included logistic regression and non-parametric tests (p < 0.05). Results: T. gondii IgG seropositivity was significantly higher in schizophrenia patients (29 %) than in controls (18.2 %) (p = 0.044, OR = 1.84; 95 % CI: 1.01-3.34). IgM positivity and DNA detection did not differ significantly. All seropositive participants showed high IgG avidity, indicating latent infection. BPRS scores and illness duration were higher in IgG-positive individuals, but the differences were not significant. Conclusion: Latent T. gondii infection may be associated with schizophrenia. However, further multicenter studies integrating molecular and serological approaches are needed to clarify its role in disease pathogenesis.
